SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as traders speculate on the timing and results of upcoming Phase 2 maintenance data for its obesity drug, VK2735. While many investors express frustration with the CEO's communication style and lack of updates at recent industry events, sentiment remains focused on the potential for strong clinical data and a possible future partnership or acquisition.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The community is primarily discussing a massive surge in oil prices driven by escalating conflict in the Middle East, specifically reports of the Saudi East-West pipeline being damaged and Houthi-led blockades of critical shipping routes. While some traders view the price action as a sustainable response to supply constraints and global shortages, others argue it is the result of market manipulation and are betting on a sharp reversal.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

CRCL is trending as investors react to the upcoming Senate procedural vote on the Digital Asset Market Clarity Act, with traders divided between optimism over potential regulatory progress and skepticism regarding the bill's ability to clear the 60-vote threshold. The sentiment is further influenced by broader volatility in crypto-linked equities and debates over the impact of the proposed stablecoin yield provisions on traditional banking.

Vera Therapeutics, Inc. is a clinical stage biotechnical company, which engages in the development and commercialization of transformative treatments for immunological diseases. Its product includes the TRUTAKNA injection. The company was founded by Marshall W. Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is trending following the company's submission of a Biologics License Application (BLA) to the FDA for atacicept as a treatment for IgA nephropathy. The community sentiment is largely bullish, with many traders highlighting the drug's clinical trial results and potential first-mover advantage as key catalysts.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is facing significant selling pressure and reaching new 52-week lows, with traders debating whether this is a structural downturn driven by high interest rates and macro headwinds or a temporary period of exploitation by market makers. While some investors remain committed to the long-term thesis and institutional holdings, others are expressing frustration over management silence, ongoing share dilution, and the stock's failure to react to positive acquisitions and analyst price targets.

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Forgent Power Solutions is trending following record fiscal fourth-quarter results, highlighted by strong earnings, high bookings, and a record $3 billion backlog. The community is bullish on the company's growth trajectory and its role in meeting the power infrastructure demands of AI data centers, though some traders have noted near-term volatility related to recent share offerings.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is seeing significant price volatility and heavy trading volume as traders debate the company's long-term growth potential against persistent market manipulation and heavy insider selling. While some investors remain bullish due to strong earnings and rising global natural gas prices, others are frustrated by consistent institutional selling and aggressive short-selling activity around key option levels.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending as traders debate the company's long-term potential within the evolving military drone landscape and the anticipated timing of major government contracts. While some investors express frustration over the pace of procurement and lack of official announcements, others are focused on upcoming industrial events and the broader industry shift toward domestic drone production.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is experiencing a period of volatility as traders weigh the company's strong long-term contract backlog and data center expansion against macroeconomic pressures, including concerns over interest rate hikes and broader tech sector sentiment. While many investors remain bullish on the long-term potential of the AI infrastructure buildout, the conversation is marked by frustration over a lack of immediate catalysts and persistent downward price pressure.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending as traders debate the company's timeline for commercializing its solid-state battery technology, with discussions fueled by uncertainty surrounding potential partnerships, including speculation regarding the Tesla Roadster and Volkswagen's restructuring. Community sentiment is deeply divided between long-term investors waiting for production milestones and skeptics pointing to a lack of revenue, insider selling, and repeated delays.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$BNTX 
Investors on here are so ridiculous. They are upset that Moderna moved but this didn’t. What does this tell us? It tells us that it’s not the science that moved Moderna, because if it was it should have never hit the $20’s. It was a short squeeze possibly caused by retailers accumulating on news and some short covering. So in time that will come down from the sky and meet this company in valuation. Based off the price action of BioNtech it is appropriately priced because its sales are years away from producing fruit, and even then its execution risk. So with that all being said, expect a gradual grinding of BNTX at current levels for the foreseeable future and Moderna to come back below $100 again because science alone isn’t enough, it’s cash flows that matter more and both are in negative territory.

MIJACology MIJACology

John

StockTwits for iOS

BioNTech SE - ADR

 
Investors on here are so ridiculous. They are upset that Moderna moved but this didn’t. What does this tell us? It tells us that it’s not the science that moved Moderna, because if it was it should have never hit the $20’s. It was a short squeeze possibly caused by retailers accumulating on news and some short covering. So in time that will come down from the sky and meet this company in valuation. Based off the price action of BioNtech it is appropriately priced because its sales are years away from producing fruit, and even then its execution risk. So with that all being said, expect a gradual grinding of BNTX at current levels for the foreseeable future and Moderna to come back below $100 again because science alone isn’t enough, it’s cash flows that matter more and both are in negative territory.